Is pbr a good buy right now?

**Petrobras' stock presents a complex investment scenario**. Here's an analysis to help you decide if it's a good buy right now:

1. **Financial Performance and Analyst Ratings**:
- Petrobras reported an EPS of $0.707 in the last quarter, which missed the consensus estimate of $0.849. This could indicate underlying issues with profitability.
- Despite this, analysts have set an average price target of $17.80, suggesting a potential upside of 4.46% from the last price of $17.04. This average price target is based on 6 Wall Street analysts offering 12-month price targets.

|code|stock code|stock name|last-price|last-change|Rating Firm[20240524-20240626]|Rating Analyst[20240524-20240626]|Current Rating[20240524-20240626]|Previous Rating[20240524-20240626]|Rating Action[20240524-20240626]|Current Price Target[20240524-20240626]|Previous Price Target[20240524-20240626]|Price Target Action[20240524-20240626]|Percentage Change in Price Target[20240524-20240626]|Rating Date[20240524-20240626]|Current Rating (AIME)[20240524-20240626]|Previous Rating (AIME)[20240524-20240626]|Price to Book Ratio[20240626]|market_code|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|AMSWA|AMSWA.O|American Software|8.4700|-0.7034|B. Riley Securities|Zachary Cummins|Buy|Buy|Maintains|14|16|Lowers|-0.125|20240607|Strong Buy|Strong Buy|2.1590|185|
|STNE|STNE.O|StoneCo|11.7200|-1.8425|JP Morgan|Yuri Fernandes|Overweight|Neutral|Upgrades|20|20|Maintains|0|20240606|Buy|Neutral|1.2184|185|
|ODD|ODD.O|ODDITY Tech|38.6900|0.2591|Truist Securities|Youssef Squali|Buy|Buy|Reiterates|58|58|Maintains|0|20240607|Strong Buy|Strong Buy|6.6607|185|
|ODD|ODD.O|ODDITY Tech|38.6900|0.2591|Truist Securities|Youssef Squali|Buy|Buy|Maintains|60|58|Raises|0.034482758620689655|20240612|Strong Buy|Strong Buy|6.6607|185|
|CALT|CALT.O|Calliditas|38.4800|-0.9141|Citigroup|Yigal Nochomovitz|Neutral|Buy|Downgrades|39||Announces||20240531|Neutral|Strong Buy|101.9268|185|
|RCUS|RCUS.N|Arcus Biosciences|15.3400|-3.0954|Citigroup|Yigal Nochomovitz|Buy|Buy|Maintains|38|36|Raises|0.05555555555555555|20240603|Strong Buy|Strong Buy|1.9747|169|
|SMMT|SMMT.O|Summit Therapeutics|7.7700|-2.9963|Citigroup|Yigal Nochomovitz|Buy|Buy|Maintains|13|7|Raises|0.8571428571428571|20240531|Strong Buy|Strong Buy|123.0568|185|
|STTK|STTK.O|Shattuck|3.7300|4.9226|Citigroup|Yigal Nochomovitz|Buy|Buy|Maintains|9|10|Lowers|-0.1|20240617|Strong Buy|Strong Buy|1.3917|185|
|CRWD|CRWD.O|CrowdStrike Holdings|381.6300|-1.3264|Cantor Fitzgerald|Yi Fu Lee|Overweight|Overweight|Reiterates|400|400|Maintains|0|20240621|Buy|Buy|36.5529|185|
|CYBR|CYBR.O|CyberArk Software|262.9850|0.0894|Cantor Fitzgerald|Yi Fu Lee|Overweight|Overweight|Reiterates|300|300|Maintains|0|20240621|Buy|Buy|13.5544|185|

2. **Recent Events and Market Sentiment**:
- The stock has been volatile, with a recent 3.3% drop in the U.S.-listed shares. This volatility could be indicative of market uncertainty or risk.
- The company's board approved the nomination of Magda Chambriard as the new CEO, which could signal a strategic shift or renewal in management.
3. **Dividend and Valuation Metrics**:
- Petrobras has a history of paying dividends, with a recent variable dividend of $0.03 per share. This could be attractive to income-focused investors.
- The company's P/E ratio is -19416.16, which is extremely high and suggests that the company is not currently profitable as measured by traditional metrics.
- The P/S ratio is 0.62, which is relatively low, indicating that the stock may be undervalued compared to its sales.

|code|stock code|stock name|last-price|last-change|Total Revenue year-on-year growth rate[20240331]|Price to Book Ratio[20240626]|Net Profit Margin[20240331]|Net Income[20240331]|Dividend Yield (TTM)[20240625]|Basic EPS[20240331]|market_code|
|---|---|---|---|---|---|---|---|---|---|---|---|
|BIAF|BIAF.O|bioAffinity|1.9350|0.7813|261180.23887079261|4.2798|-81.5252|-1961815||-0.2|186|
|SKYX|SKYX.O|SKYX Platforms|1.1200|2.7523|189204.9476309227|8.2381|-50.9869|-9676201||-0.1|186|
|MPU|MPU.A|Mega Matrix|2.3650|0.2119|102154.11764705883|5.2743|-22.2709|-1935700||-0.05|170|
|ENVX|ENVX.O|Enovix|15.1900|-6.5806|25004.761904761905|11.1293|-881.9613|-4.6497E7||-0.28|186|
|LPCN|LPCN.O|Lipocine|7.8499|-3.6822|13751.925804691762|1.7524|46.1276|3513621||0.66|186|
|IPWR|IPWR.O|Ideal Power|6.7518|0.1751|11758.28313253012|2.3897|-3136.4711|-2469626||-0.39|186|
|VRCA|VRCA.O|Verrica|7.0850|0.6392|10240.54054054054|198.3166|-531.3905|-2.0331E7||-0.44|185|
|CEI|CEI.A|Camber Energy|0.1169|1.6522|8771.769853751432|1.9325|-317.7747|-2.6351568E7||-0.19|170|
|BKKT|BKKT.N|Bakkt Holdings|18.8900|8.7507|6480.794701986755|4.4824|-2.4895|-2.1275E7||-1.86|169|
|SOWG|SOWG.O|Sow Good|20.0900|-5.7692|5633.83602272156|15.3581|4.4764|510588||0.08|186|

4. **Technical Indicators**:
- Technical indicators such as the MACD and RSI can provide insights into momentum and overbought or oversold conditions. The MACD is -0.38, and the RSI is 41.99, which could suggest a bearish sentiment in the short term.
- The stock has been trading in a wide and horizontal trend, with a recent price range of $9.55 to $17.41 over the past 12 months. This could indicate a lack of direction or a potential for a breakout.

|code|stock code|stock name|last-price|last-change|RSI[20240625]|Price to Book Ratio[20240626]|MACD[20240626]|KDJ[20240625]|Boll[20240625]|market_code|
|---|---|---|---|---|---|---|---|---|---|---|
|SEDA.U|SEDA.U.N|SDCL EDGE-U|11.1300|0.0000|100.0000|0.0000|-0.0095|-0.1152|11.1300|169|
|TCOA.U|TCOA.U.N|Zalatoris-U|11.2000|1.3575|100.0000|0.0000|-0.0126|-1.2731|11.0500|169|
|AEAEU|AEAEU.O|AltEnergy-U|11.2600|0.0000|100.0000|0.0000|0.0747|132.9218|11.0040|185|
|BHACU|BHACU.O|Focus Impact BH3-U|10.5000|0.2865|100.0000|0.0000|0.0031|0.0000|10.4700|185|
|BRACU|BRACU.O|Broad Capital-U|12.0400|0.0000|100.0000|0.0000|0.1507|126.3374|11.4730|185|
|CCIX|CCIX.O|Churchill|10.0400|0.0000|100.0000|60860.8420|0.0007|52.7778||185|
|IVCBU|IVCBU.O|Investcorp Europe-U|11.8000|0.0000|100.0000|0.0000|0.0682|129.6296|11.5450|185|
|MCACU|MCACU.O|Monterey Capital-U|11.4000|0.0000|100.0000|0.0000|0.0223|-16.1111|11.1660|185|
|PLAOU|PLAOU.O|Patria Latin-U|12.1500|7.1429|100.0000|0.0000|0.0954|-24.1254|11.3280|185|
|RENEU|RENEU.O|Cartesian Growth-U|11.2700|0.0000|100.0000|0.0000|-0.0044|-4.1977|11.2550|185|

5. **Institutional Activity and Market Perception**:
- There have been recent changes in institutional holdings, with some firms reducing their stakes and others increasing them. This could indicate differing opinions among large investors.
- The consensus rating among analysts is a "Hold," with some recommending a "Buy" and others a "Neutral" or "Sell". This mixed sentiment reflects uncertainty about the stock's future performance.

In conclusion, while there are some positive indicators, such as the potential upside based on analysts' price targets and the history of dividend payments, there are also significant concerns, including the company's recent financial performance, high P/E ratio, and current volatility. Investors should carefully consider these factors and their own risk tolerance before making a decision. It's also advisable to monitor the company's upcoming earnings reports and any further changes in analyst ratings or institutional holdings.